Financial Technology and Innovation of Biomedical Enterprises
- DOI
- 10.2991/978-94-6463-702-1_16How to use a DOI?
- Keywords
- Financial technology; Biomedicine; Enterprise innovation; Financing constraint
- Abstract
We discusses the influence of financial technology on the innovation of biomedical enterprises, and analyzes its mechanism. It is found that financial technology has significantly promoted the innovation activities of biomedical enterprises by reducing information asymmetry and financing constraints. Financial technology provides enterprises with convenient financing channels, abundant information resources and effective risk management tools, thus improving their R&D efficiency and innovation ability. This paper also puts forward some policy suggestions, including that the government should provide policy support, optimize the financing environment and strengthen intellectual property protection; Enterprises should actively embrace financial technology and use it to optimize R&D processes and reduce innovation risks; Financial technology service providers should design customized products and services to support the innovative activities of biomedical enterprises. Future research can further explore the long-term impact of financial technology on the innovation of biomedical enterprises, the differences between different countries or regions and the application of financial technology in specific market segments.
- Copyright
- © 2025 The Author(s)
- Open Access
- Open Access This chapter is licensed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.
Cite this article
TY - CONF AU - Yifan Bao PY - 2025 DA - 2025/05/05 TI - Financial Technology and Innovation of Biomedical Enterprises BT - Proceedings of the 2025 10th International Conference on Financial Innovation and Economic Development (ICFIED 2025) PB - Atlantis Press SP - 152 EP - 162 SN - 2352-5428 UR - https://doi.org/10.2991/978-94-6463-702-1_16 DO - 10.2991/978-94-6463-702-1_16 ID - Bao2025 ER -